Nuvasive

Visual Financials
Company Name: NuVasive Inc
Ticker Symbol: NUVA
CIK Number: 0001142596
WWW Address: http://www.nuvasive.com
CEO: Mr. Gregory T. Lucier
No. of Employees: 1,500
Common Issue Type: CS
Business Description:NuVasive, Inc, is a medical device company that designs, develops and markets products for the surgical treatment of spine disorders and general back related pains.

 
Industry Information: HEALTH SERVICES - Medical Instruments & Supplies [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 77.51 Up 1.97 77.51 77.56 76.13 77.12 75.13 392944
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 3,926.9 50.7 0.00 0.74 0.00 103.9 0.0 81.06 - 56.70
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close75.53$
PE Ratio - LTM103.9
Market Capitalisation3,926.9mil
Latest Shares Outstanding50.7mil
Earnings pS (EPS)0.74$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee506,354$
Effective Tax Rate0.5%
Float45.2mil
Float as % of Shares Outstanding0.9%
Foreign Sales130mil
Domestic Sales832mil
Selling, General & Adm/tive (SG&A) as % of Revenue0.60%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin75.0%
EBITDA Margin21.6%
Pre-Tax Profit Margin0.0%
Assets Turnover67.3%
Return on Assets (ROA)2.6%
Return on Equity (ROE)5.3%
Return on Capital Invested (ROCI)5.0%
Current Ratio2.4
Leverage Ratio (Assets/Equity)2.3
Interest Cover2.6
Total Debt/Equity (Gearing Ratio)0.90
LT Debt/Total Capital45.0%
Working Capital pS6.57$
Cash pS0.00$
Book-Value pS13.69$
Tangible Book-Value pS-1.62$
Cash Flow pS2.26$
Free Cash Flow pS0.29$
KEY FIGURES (LTM): Price info
Price/Book Ratio5.61
Price/Tangible Book Ratio0.00
Price/Cash Flow34.0
Price/Free Cash Flow270.3
P/E as % of Industry Group1,456.0%
P/E as % of Sector Segment1,173.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----1.1624,0051,086,969
4 Weeks81.0673.1175.361.81583,86212,261,102
13 Weeks81.0670.1475.311.8-1581,74137,231,447
26 Weeks81.0665.7166.7115.08523,96666,019,797
52 Weeks81.0656.7058.7430.612549,144138,384,371
YTD81.0665.71-15.99532,02064,906,472
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
76.5577.4374.9572.4270.160.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.120.40.12
Income0.30.68
Dividend0.0
Capital Spending0.20NA0.17
R&D8.11NA-3.66
Normalized Inc.0.00NA-12.06
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %5.25.214.8
Earnings %-11.4-11.40.0
EPS %0.00.00.0
EPS $0.000.001.80
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio21.20
Current Ratio2.4
Quick Ratio (Acid Test)1.3
Liquidity Ratio (Cash)1.27
Receivables Turnover6.4
Average Collection Period56
Working Capital/Equity47.9
Working Capital pS6.58
Cash-Flow pS2.89
Free Cash-Flow pS1.15
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio3.77
Financial Leverage Ratio (Assets/Equity)0.9
Debt Ratio39.9
Total Debt/Equity (Gearing Ratio)0.90
LT Debt/Equity0.81
LT Debt/Capital Invested47.9
LT Debt/Total Liabilities90.1
Interest Cover2.6
Interest/Capital Invested3.05
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio2.48
Current P/E Ratio - LTM103.90
Enterprise Value (EV)/EBITDA21.44
Enterprise Value (EV)/Free Cash Flow73.30
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM5.61
Price/Cash Flow Ratio34.0
Price/Free Cash Flow Ratio - LTM270.3
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM322.1
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio82.7
5-Y Low P/E Ratio12.6
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E64
P/E as % of Industry Group1,456.0
P/E as % of Sector Segment1,173.0
Current 12 Month Normalized P/E Ratio - LTM61.8
PER SHARE FIGURES
LT Debt pS13.08
Current Liabilities pS5.62
Tangible Book Value pS - LTM-1.62
Book Value pS - LTM13.69
Capital Invested pS26.08
Cash pS - LTM0.00
Cash Flow pS - LTM2.26
Free Cash Flow pS - LTM0.29
Earnings pS (EPS)0.74
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin6.44
Free Cash Flow Margin 5YEAR AVG6.28
Net Profit Margin0.0
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity1.38
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.73
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.70
Return on Assets (ROA)0.0
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin75.0
Gross Profit Margin - 5YEAR AVRG.0.8
EBITDA Margin - LTM21.6
EBIT Margin - LTM10.9
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate3.8
Effective Tax Rate - 5YEAR AVRG.8.3
EFFICIENCY RATIOS
Cash Conversion Cycle3,023,446
Revenue per Employee506,354
Net Income per Employee19,551
Average Collection Period3,023,446
Receivables Turnover6.4
Day's Inventory Turnover Ratio
Inventory Turnover1.3
Inventory/Sales21.6
Accounts Payble/Sales7.36
Assets/Revenue1.43
Net Working Capital Turnover2.89
Fixed Assets Turnover0.97
Total Assets Turnover0.7
Revenue per $ Cash6.26
Revenue per $ Plant5.30
Revenue per $ Common Equity1.38
Revenue per $ Capital Invested0.73
Selling, General & Adm/tive (SG&A) as % of Revenue55.5
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue5.0
R&D Expense as % of Revenue - 5YEAR AVRG.5.0

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.